AMGN FY 2013 Earnings Report — Amgen Inc. Revenue & Financial Results | Market Cap Arena

FY 2013 Earnings

Reported February 24, 2014

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2013	Prior Q	FY 2012	QoQ Change	YoY Change
Revenue	$18.7B	—	$17.3B	—	8.2%
Op. Income	$5.9B	—	$5.6B	—	5.2%
Gross Margin	82.1%	—	83.1%	—	-1.0pp
Net Margin	27.2%	—	25.2%	—	2.0pp
EPS (Diluted)	$6.64	—	$5.52	—	20.3%
Free Cash Flow	$5.6B	—	$5.2B	—	7.8%

Revenue Flow

Item	Amount
REVENUE	$18.7B
Cost of Revenue	$3.3B
GROSS PROFIT	$15.3B
R&D Expenses	$4.1B
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$5.2B
Other Expenses	$196M
Operating Expenses	$9.5B
Cost & Expenses	$12.8B
OPERATING INCOME	$5.9B
Interest Income	$420M
Interest Expense	$1.0B
Other Income/Expenses	-$602M
INCOME BEFORE TAX	$5.3B
Income Tax Expense	$184M
Net Income from Continuing Ops	$5.1B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$5.1B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$5.1B
D&A	$1.3B
EBIT	$6.3B
EBITDA	$7.6B
EPS	$7
EPS Diluted	$7

Income Statement

Item	Amount
REVENUE	$18.7B
Cost of Revenue	$3.3B
GROSS PROFIT	$15.3B
R&D Expenses	$4.1B
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$5.2B
Other Expenses	$196M
Operating Expenses	$9.5B
Cost & Expenses	$12.8B
OPERATING INCOME	$5.9B
Interest Income	$420M
Interest Expense	$1.0B
Other Income/Expenses	-$602M
INCOME BEFORE TAX	$5.3B
Income Tax Expense	$184M
Net Income from Continuing Ops	$5.1B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$5.1B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$5.1B
D&A	$1.3B
EBIT	$6.3B
EBITDA	$7.6B
EPS	$7
EPS Diluted	$7

Cash Flow Statement

Item	Amount
Net Income	$5.1B
Depreciation & Amortization	$1.3B
Stock-Based Compensation	$403M
Deferred Income Tax	-$189M
Other Non-Cash Items	$103M
Change in Working Capital	-$393M
OPERATING CASH FLOW	$6.3B
Capital Expenditure	-$693M
Acquisitions (Net)	-$9.4B
Purchases of Investments	-$22.0B
Sales/Maturities of Investments	$24.2B
Other Investing Activities	-$590M
NET CASH FROM INVESTING	-$8.5B
Net Debt Issuance	$4.7B
Common Stock Repurchased	-$832M
Common Dividends Paid	-$1.4B
Other Financing Activities	$290M
NET CASH FROM FINANCING	$2.7B
FREE CASH FLOW	$5.6B
Net Change in Cash	$548M

Balance Sheet

Item	Amount
Cash & Equivalents	$3.8B
Short-Term Investments	$15.6B
Net Receivables	$2.7B
Inventory	$3.0B
Other Current Assets	$2.3B
TOTAL CURRENT ASSETS	$27.4B
PP&E (Net)	$5.3B
Goodwill	$15.0B
Intangible Assets	$13.3B
Long-Term Investments	$3.4B
Tax Assets	$0
Other Non-Current Assets	$1.8B
TOTAL NON-CURRENT ASSETS	$38.8B
TOTAL ASSETS	$66.1B
Account Payables	$787M
Short-Term Debt	$2.5B
Deferred Revenue	$0
Other Current Liabilities	$1.3B
TOTAL CURRENT LIABILITIES	$7.9B
Long-Term Debt	$29.6B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$3.5B
Other Non-Current Liabilities	$3.0B
TOTAL NON-CURRENT LIABILITIES	$36.1B
TOTAL LIABILITIES	$44.0B
Common Stock	$29.9B
Additional Paid-In Capital	$0
Retained Earnings	-$7.6B
Treasury Stock	$0
Accum. Other Comp. Income	-$161M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$22.1B
Minority Interest	$0
TOTAL EQUITY	$22.1B
TOTAL LIABILITIES & EQUITY	$66.1B
Total Debt	$32.1B
Net Debt	$28.3B